ROIV vs UTHR
Roivant Sciences vs United Therapeutics — AI-powered side-by-side comparison
| Metric | ROIV | UTHR |
|---|---|---|
| AI Score | 52 | 59 |
| Price | $34.95 | $536.00 |
| P/E Ratio | -75.67× | 18.08× |
| ROE | -0.1% | 0.2% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.8% | 0.9% |
| Debt / Equity | 0.02× | 0.00× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 43.9 | 38.7 |
| Beta | 1.108 | 0.58 |
| Expected Upside | — | +14.5% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ROIV Full Analysis
UTHR Full Analysis